(PDF) Effects of Intravitreal Ranibizumab on the Untreated

Effects of Intravitreal Ranibizumab on the Untreated Eye and Systemic Gene Expression Profile in Age-Related Macular Degeneration [Corrigendum]

Clinical Interventions in Aging - New Zealand

doi 10.2147/cia.s111527

Full Text

Abstract

Available in full text

Categories

Date

June 1, 2016

Authors

Katarzyna Michalska-Malecka

Małgorzata Kimsa

Barbara Strzałka-Mrozik

Maria Formińska-Kapuścik

Małgorzata Nita

Urszula Mazurek

Publisher

Informa UK Limited

Related search

Effect of ARMS2 Gene Polymorphism on Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration

Genetics and Molecular Research

Molecular Biology

English

Early Changes in Retinal Thickness When Using Intravitreal Ranibizumab for Age‐related Macular Degeneration

Acta Ophthalmologica

English

Choroidal Blood Flow After the First Intravitreal Ranibizumab Injection in Neovascular Age-Related Macular Degeneration Patients

Acta Ophthalmologica

English

Peripapillary Choroidal Thickness After Intravitreal Ranibizumab Injections in Eyes With Neovascular Age-Related Macular Degeneration

BMC Ophthalmology

English

Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine

English

Focal Macular Electroretinograms After Intravitreal Injections of Bevacizumab for Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science

Molecular Neuroscience

Sensory Systems

English

Intravitreal Injection of Ranibizumab Using A pro Re Nata Regimen for Age-Related Macular Degeneration and Vision-Related Quality of Life

Clinical Ophthalmology

English

Ranibizumab in Neovascular Age-Related Macular Degeneration: A 5-Year Follow-Up

Clinical Ophthalmology

English

Ranibizumab Monotherapy in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment

Journal of Clinical & Experimental Ophthalmology

English